Actively Recruiting
Prospective Registry Observing Vaginal Photobiomodulation with SoL Pelvic Therapy for Chronic Pelvic Pain
Led by SoLa Pelvic Therapy · Updated on 2026-09-02
1000
Participants Needed
1
Research Sites
52 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are collecting real-world data on the use of SoL Pelvic Therapy SPT for patients with chronic pelvic pain. This multicenter, prospective, observational registry aims to evaluate how SPT is used in clinical practice and to gather safety information. The study follows patients receiving transvaginal photobiomodulation PBM therapy as part of their regular medical care without assigning treatments. Participants receive SoL Pelvic Therapy through their usual healthcare providers, who decide on patient selection, treatment frequency, and any additional therapies. The registry does not control or assign treatments but observes how SPT is used in real life. Patients are followed for 12 months from the start of therapy to monitor device use, safety, and outcomes reported by patients. During participation, patients provide information about their treatment and pain levels. Researchers collect safety data and assess changes in chronic pelvic pain severity over 12 months. This observational registry supports understanding the long-term use and effects of SPT while patients continue their normal care routines.
CONDITIONS
Brief Title
A Prospective Registry of Vaginal Photobiomodulation for Chronic Pelvic Pain.
Research Team
G
Georgine Lamvu, MD, MPH
P
Pilar Garcia, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here